Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1021/acs.jpclett.0c02397

http://scihub22266oqcxt.onion/10.1021/acs.jpclett.0c02397
suck pdf from google scholar
33508197!ä!33508197

suck abstract from ncbi


Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33508197      J+Phys+Chem+Lett 2021 ; 12 (5): 1384-1389
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • On Drug-Membrane Permeability of Antivirals for SARS-CoV-2 #MMPMID33508197
  • Liu C; Elvati P; Violi A
  • J Phys Chem Lett 2021[Feb]; 12 (5): 1384-1389 PMID33508197show ga
  • One of the key parameters required to identify effective drugs is membrane permeability, as a compound intended for an intracellular target with poor permeability will have low efficacy. In this paper, we leverage a computational approach recently developed by our group to study the interactions between nanoparticles and mammalian membranes to study the time of entry of a variety of drugs into the viral envelope of coronavirus as well as cellular organelles. Using a combination of all-atoms molecular dynamics simulations and statistical analysis, we consider both drug characteristics and membrane properties to determine the behavior of 79 drugs and their interactions with the viral envelope, composed of the membrane and spike protein, as well as five other membranes that correspond to various mammalian compartments (lysosome, plasma, Golgi, mitochondrial, and endoplasmic reticulum membranes). The results highlight important trends that can be exploited for drug design, from the relatively high permeability of the viral envelope and the effect of transmembrane proteins, to the differences in permeability between organelles. When compared with bioavailability data present in the literature, the model results suggest a negative correlation between time of permeation and bioavailability of promising drugs. The method is general and flexible and can be employed for a variety of molecules, from small drugs to small nanoparticles, as well to a variety of biological membranes. Overall, the results indicate that this model can contribute to the identification of successful drugs as it predicts the ability of compounds to reach both intended and unintended intracellular targets.
  • |*COVID-19 Drug Treatment[MESH]
  • |Antiviral Agents/*metabolism[MESH]
  • |Binding Sites[MESH]
  • |Humans[MESH]
  • |Hydrophobic and Hydrophilic Interactions[MESH]
  • |Kinetics[MESH]
  • |Lipid Bilayers/chemistry[MESH]
  • |Membrane Glycoproteins/chemistry[MESH]
  • |Models, Biological[MESH]
  • |Molecular Dynamics Simulation[MESH]
  • |Nanoparticles/chemistry[MESH]
  • |Particle Size[MESH]
  • |Permeability[MESH]
  • |Protein Binding[MESH]
  • |SARS-CoV-2/*drug effects[MESH]
  • |Solubility[MESH]
  • |Spike Glycoprotein, Coronavirus/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box